• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Fresenius Helios closes acquisition of Quirónsalud

Share:

October 28, 2018

Fresenius Helios closed its €5.76 billion acquisition of IDC Salud Holding S.L.U. today, as planned. Quirónsalud will be consolidated as of February 1, 2017.

Of the total purchase price for Spain’s largest private hospital operator, €5.36 billion had already been debt-financed. The balance of €400 million was paid in the form of 6,108,176 new Fresenius shares issued today from authorized capital excluding subscription rights.

Quirónsalud’s network is comprised of 43 hospitals, 39 outpatient centers and about 300 Occupational Risk Prevention centers located in all economically important areas of Spain. The company has about 35,000 employees and offers the full spectrum of inpatient and outpatient care. With the acquisition, Fresenius Helios strengthens its position as Europe’s largest private hospital operator.

Date: October 29, 2018

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Source: Fresenius

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Nuclear Medicine or Radiopharmaceuticals Market Modest Analysis with Global Business Trends, Share, Progress Insight, Statistics, Regional and Forecast to 2026Nuclear Medicine or Radiopharmaceuticals Market Modest Analysis with Global Business Trends, Share, Progress Insight, Statistics, Regional and Forecast to 2026
  • Allscripts’ Practice Fusion Admits to Illegal Kickbacks from Opioid Maker, Agrees to $145M SettlementAllscripts’ Practice Fusion Admits to Illegal Kickbacks from Opioid Maker, Agrees to $145M Settlement
  • Melinta Therapeutics to Acquire Tetraphase PharmaceuticalsMelinta Therapeutics to Acquire Tetraphase Pharmaceuticals
  • 4 Hospitals Leveraging Social Media to Improve Patient Engagement4 Hospitals Leveraging Social Media to Improve Patient Engagement
  • Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600Eton Pharmaceuticals Announces Acquisition of Rare Disease Product Candidate ET-600
  • Europe’s Pharmaceutical Future Innovation Under PressureEurope’s Pharmaceutical Future Innovation Under Pressure
  • CVR Medical Agrees Proposed Acquisition of CVR GlobalCVR Medical Agrees Proposed Acquisition of CVR Global
  • In-Home Care Company DispatchHealth Raises $135.8M, Backed by Optum Ventures and HumanaIn-Home Care Company DispatchHealth Raises $135.8M, Backed by Optum Ventures and Humana

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications